← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2000Last known activity
Jun 30, 2018
Timeline
2000s
- Jan 1, 2000
Cystic Fibrosis Foundation Therapeutics— Founded
Drugs by trial phase (57 distinct, 70 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT03265288CollaboratorPhase 2Jun 30, 2018
- NCT03482960CollaboratorEarly Phase 1May 29, 2018
- NCT03451045CollaboratorPhase 2Dec 22, 2017
- NCT03020719CollaboratorPhase 2Jun 14, 2017
- NCT02819856CollaboratorPhase 1/Phase 2May 1, 2017
- NCT02498535CollaboratorPhase 2Feb 22, 2017
- NCT02866721CollaboratorPhase 1Aug 1, 2016
- NCT02950883CollaboratorPhase 2/Phase 3Aug 1, 2016
- NCT02677701CollaboratorPhase 4Apr 1, 2016
- NCT02354859CollaboratorPhase 2Mar 1, 2016
- NCT02694393CollaboratorPhase 1/Phase 2Feb 1, 2016
- NCT02378467CollaboratorN/AMar 1, 2015
- NCT02202876CollaboratorN/ANov 1, 2014
- NCT02372383CollaboratorN/AOct 1, 2014
- NCT03391414CollaboratorPhase 1Aug 31, 2014
Details
- Founded
- Bethesda, MD, US Jan 1, 2000
- Last known activity
- Jun 30, 2018